Who we are

Meet our team.

We have assembled a team of experienced scientists and industry pioneers, including cancer and diagnostic experts and accomplished company builders who are passionate about changing the outlook of a cancer diagnosis.

Our investors include Third Rock Ventures, Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, Invus and others – leading investors in the fields of cancer diagnosis and treatment.

Semi Trotto General Manager View Bio ›

Christoph Lengauer, Ph.D. Co-Founder and Chief Innovation Officer; Partner, Third Rock Ventures View Bio ›

Sam Asgarian, M.D. Chief Medical Officer View Bio ›

Seema Singh Bhan SVP, Public Policy and External Affairs View Bio ›

Isaac Kinde, M.D., Ph.D. Co-Founder, Head of Research and Innovation View Bio ›

Frank Diehl, Ph.D. EVP, Product Solutions View Bio ›

Kenneth W. Kinzler, Ph.D. Professor of Oncology, Co-Director of the Ludwig Institute at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University View Bio ›

Nickolas Papadopoulos, Ph.D. Professor of Oncology and Pathology at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University View Bio ›

Bert Vogelstein, M.D. Clayton Professor of Oncology and Pathology and Co-Director of the Ludwig Institute at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; Investigator, Howard Hughes Medical Institute View Bio ›

Learn More

About our work.

What We Do